Determination of Nitrosamines in Active Pharmaceutical Ingredients

Applications | 2020 | Agilent TechnologiesInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Improved LC/MS Performance to Determine Polar Nitrosamines Using the Agilent 1260 Infinity II Hybrid Multisampler
Highly sensitive and robust LC-HRAM-MS method for simultaneous quantitation of sixteen nitrosamines in multiple drug products
Highly sensitive method for the determination of 12 nitrosamine impurities in multiple ARBs, the class of sartan drug formulations
Determination of Nitrosamine Impurities Using the Agilent 6475 Triple Quadrupole LC/MS System